CLINICAL_TRIALS
trial_result
· 2024-12-11
Clinical Trial Update: Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness [Phase 3]
Summary
Phase 3 trial evaluating Tradipitant for motion sickness has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanda Pharmaceuticals | Conditions: Motion Sickness | Phase 3 | Status: COMPLETED | Results posted: 2024-12-11